DE60233574D1 - Verfahren und zusammensetzungen zum nachweis des aktivierungszustands multipler proteine in einzelzellen - Google Patents
Verfahren und zusammensetzungen zum nachweis des aktivierungszustands multipler proteine in einzelzellenInfo
- Publication number
- DE60233574D1 DE60233574D1 DE60233574T DE60233574T DE60233574D1 DE 60233574 D1 DE60233574 D1 DE 60233574D1 DE 60233574 T DE60233574 T DE 60233574T DE 60233574 T DE60233574 T DE 60233574T DE 60233574 D1 DE60233574 D1 DE 60233574D1
- Authority
- DE
- Germany
- Prior art keywords
- compositions
- detecting
- individual cells
- activation condition
- multiple proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5302—Apparatus specially adapted for immunological test procedures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
- G01N2021/6441—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks with two or more labels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96466—Cysteine endopeptidases (3.4.22)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
- G01N2440/14—Post-translational modifications [PTMs] in chemical analysis of biological material phosphorylation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/973—Simultaneous determination of more than one analyte
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30443401P | 2001-07-10 | 2001-07-10 | |
US31014101P | 2001-08-02 | 2001-08-02 | |
PCT/US2002/022328 WO2003067210A2 (en) | 2001-07-10 | 2002-07-10 | Methods and compositions for detecting the activation state of the multiple proteins in single cells |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60233574D1 true DE60233574D1 (de) | 2009-10-15 |
Family
ID=27737231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60233574T Expired - Lifetime DE60233574D1 (de) | 2001-07-10 | 2002-07-10 | Verfahren und zusammensetzungen zum nachweis des aktivierungszustands multipler proteine in einzelzellen |
Country Status (7)
Country | Link |
---|---|
US (6) | US7563584B2 (de) |
EP (1) | EP1415156B1 (de) |
JP (1) | JP4401172B2 (de) |
AT (1) | ATE441857T1 (de) |
AU (1) | AU2002365421A1 (de) |
DE (1) | DE60233574D1 (de) |
WO (1) | WO2003067210A2 (de) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090118139A1 (en) * | 2000-11-07 | 2009-05-07 | Caliper Life Sciences, Inc. | Microfluidic method and system for enzyme inhibition activity screening |
US7695926B2 (en) | 2001-07-10 | 2010-04-13 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for detecting receptor-ligand interactions in single cells |
ATE441857T1 (de) * | 2001-07-10 | 2009-09-15 | Univ Leland Stanford Junior | Verfahren und zusammensetzungen zum nachweis des aktivierungszustands multipler proteine in einzelzellen |
US7393656B2 (en) * | 2001-07-10 | 2008-07-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for risk stratification |
US7381535B2 (en) * | 2002-07-10 | 2008-06-03 | The Board Of Trustees Of The Leland Stanford Junior | Methods and compositions for detecting receptor-ligand interactions in single cells |
US20040197836A1 (en) * | 2003-04-04 | 2004-10-07 | Hashemi Brian B. | Measurement of F-actin in whole blood cellular subsets |
EP2371835A1 (de) * | 2003-07-03 | 2011-10-05 | The Trustees Of The University Of Pennsylvania | Inhibition der Syk-Kinaseexpression |
US20060141549A1 (en) * | 2004-08-03 | 2006-06-29 | Sudipta Mahajan | Cell-based kinase assay |
CA2593355A1 (en) * | 2005-01-24 | 2006-07-27 | The Board Of Trustees Of The Leland Stanford Junior University | Method for modeling cell signaling systems by means of bayesian networks |
WO2007117423A2 (en) | 2006-03-31 | 2007-10-18 | Cira Discovery Sciences, Inc. | Method and apparatus for representing multidimensional data |
US8771971B2 (en) * | 2006-07-28 | 2014-07-08 | The Research Foundation Of State University Of New York | Methods and kits for measurement of lymphocyte function |
EP2860247A1 (de) | 2007-08-21 | 2015-04-15 | Nodality, Inc. | Diagnose-, Prognose- und Behandlungsverfahren |
US20090155838A1 (en) * | 2007-11-28 | 2009-06-18 | Smart Tube, Inc. | Devices, systems and methods for the collection, stimulation, stabilization, and analysis of a biological sample |
US20090269800A1 (en) * | 2008-04-29 | 2009-10-29 | Todd Covey | Device and method for processing cell samples |
GB2474146B (en) * | 2008-04-29 | 2013-04-10 | Nodality Inc | Methods of determining the health status of an individual |
US20090291458A1 (en) * | 2008-05-22 | 2009-11-26 | Nodality, Inc. | Method for Determining the Status of an Individual |
US9183237B2 (en) | 2008-07-10 | 2015-11-10 | Nodality, Inc. | Methods and apparatus related to gate boundaries within a data space |
US8399206B2 (en) | 2008-07-10 | 2013-03-19 | Nodality, Inc. | Methods for diagnosis, prognosis and methods of treatment |
US20100030719A1 (en) * | 2008-07-10 | 2010-02-04 | Covey Todd M | Methods and apparatus related to bioinformatics data analysis |
US8227202B2 (en) | 2008-07-10 | 2012-07-24 | Nodality, Inc. | Methods for diagnosis, prognosis and methods of treatment |
WO2010006303A2 (en) * | 2008-07-10 | 2010-01-14 | Nodality, Inc. | Methods and apparatus related to management of experiments |
US20100014741A1 (en) * | 2008-07-10 | 2010-01-21 | Banville Steven C | Methods and apparatus related to gate boundaries within a data space |
CN102144161B (zh) * | 2008-09-04 | 2016-02-17 | 贝克曼考尔特公司 | 泛激酶活化与信号通路的评估 |
ES2763537T3 (es) * | 2008-09-16 | 2020-05-29 | Beckman Coulter Inc | Diagrama de árbol interactivo para datos de citometría de flujo |
WO2010045651A1 (en) * | 2008-10-17 | 2010-04-22 | Nodality, Inc. | Methods for analyzing drug response |
US9034257B2 (en) * | 2008-10-27 | 2015-05-19 | Nodality, Inc. | High throughput flow cytometry system and method |
US8309306B2 (en) * | 2008-11-12 | 2012-11-13 | Nodality, Inc. | Detection composition |
US20100209929A1 (en) * | 2009-01-14 | 2010-08-19 | Nodality, Inc., A Delaware Corporation | Multiple mechanisms for modulation of jak/stat activity |
US20100204973A1 (en) * | 2009-01-15 | 2010-08-12 | Nodality, Inc., A Delaware Corporation | Methods For Diagnosis, Prognosis And Treatment |
US20100233733A1 (en) * | 2009-02-10 | 2010-09-16 | Nodality, Inc., A Delaware Corporation | Multiple mechanisms for modulation of the pi3 kinase pathway |
US20100215644A1 (en) * | 2009-02-25 | 2010-08-26 | Nodality, Inc. A Delaware Corporation | Analysis of nodes in cellular pathways |
US20120058464A1 (en) * | 2009-03-16 | 2012-03-08 | Eugen Ermantraut | Assay Methods Using Array of Test Zones |
US8242248B2 (en) | 2009-03-23 | 2012-08-14 | Nodality, Inc. | Kits for multiparametric phospho analysis |
US8187885B2 (en) | 2009-05-07 | 2012-05-29 | Nodality, Inc. | Microbead kit and method for quantitative calibration and performance monitoring of a fluorescence instrument |
WO2010135608A1 (en) * | 2009-05-20 | 2010-11-25 | Nodality, Inc. | Methods for diagnosis, prognosis and methods of treatment |
US20110059861A1 (en) * | 2009-09-08 | 2011-03-10 | Nodality, Inc. | Analysis of cell networks |
US9459246B2 (en) | 2009-09-08 | 2016-10-04 | Nodality, Inc. | Induced intercellular communication |
CA2805247C (en) | 2010-07-14 | 2021-08-10 | The Curators Of The University Of Missouri | Nanopore-facilitated single molecule detection of nucleic acids |
US8956859B1 (en) | 2010-08-13 | 2015-02-17 | Aviex Technologies Llc | Compositions and methods for determining successful immunization by one or more vaccines |
US9066974B1 (en) | 2010-11-13 | 2015-06-30 | Sirbal Ltd. | Molecular and herbal combinations for treating psoriasis |
US8541382B2 (en) | 2010-11-13 | 2013-09-24 | Sirbal Ltd. | Cardiac glycoside analogs in combination with emodin for cancer therapy |
US9095606B1 (en) | 2010-11-13 | 2015-08-04 | Sirbal Ltd. | Molecular and herbal combinations for treating psoriasis |
US8597695B1 (en) | 2010-11-13 | 2013-12-03 | Sirbal Ltd. | Herbal combinations for treatment of a skin condition |
US9005909B2 (en) * | 2011-01-06 | 2015-04-14 | Rigel Pharmaceuticals, Inc. | Whole blood assay for measuring AMPK activation |
US20170049687A1 (en) | 2015-07-29 | 2017-02-23 | Sirbal Ltd. | Herbal Combinations For Treating Scalp Conditions |
US20140193052A1 (en) * | 2011-08-23 | 2014-07-10 | Yoshiko Yoshihara | Information processing system, information processing method, information processing apparatus, control method thereof and control program |
CN103842813B (zh) * | 2011-09-06 | 2018-04-17 | 贝克顿·迪金森公司 | 用于对样品中的稀少目标细胞进行细胞计数检测的方法和组合物 |
CN104023760A (zh) | 2011-10-28 | 2014-09-03 | 普莱萨格生命科学公司 | 药物递送方法 |
EP2623978A1 (de) * | 2012-02-03 | 2013-08-07 | Charité - Universitätsmedizin Berlin | CD8+ T-Zell-Subpopulationen als Indikator zur Vorhersage von verzögerter Bruchheilung |
WO2013188756A1 (en) | 2012-06-15 | 2013-12-19 | The University Of Chicago | Oligonucleotide-mediated quantitative multiplexed immunoassays |
CA2894687C (en) | 2012-12-17 | 2023-08-29 | Genomatica, Inc. | Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing adipate, 6-aminocaproate, hexamethylenediamine or caprolactam related thereto |
AU2014227754B2 (en) | 2013-03-15 | 2018-03-01 | The Curators Of The University Of Missouri | Encoded nanopore sensor for multiplex nucleic acids detection |
CN105939721A (zh) | 2013-12-02 | 2016-09-14 | 塞尔巴有限公司 | 用于治疗皮肤疾病的草药组合 |
CA2945263A1 (en) | 2014-04-09 | 2015-10-15 | Christopher Rudd | Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity |
EP3274720B1 (de) * | 2015-03-26 | 2023-12-27 | University of Houston System | Integrierte funktionale und molekulare profilierung von zellen |
WO2018002015A1 (en) * | 2016-06-28 | 2018-01-04 | Ventana Medical Systems, Inc. | New colors for chromogenic ihc and ish staining with multi-dye quinone methide and tyramide conjugates |
JP2022502017A (ja) * | 2018-09-21 | 2022-01-11 | バークレー ライツ,インコーポレイテッド | 官能基化ウェルプレート、その作製及び使用方法 |
CN109557296B (zh) * | 2018-11-22 | 2022-05-20 | 珠海澳加动力生物科技有限公司 | 一种循环检测肿瘤细胞药物敏感性的方法 |
CN109975537B (zh) * | 2019-04-09 | 2022-05-24 | 上海药明生物技术有限公司 | 一种检测tim-3抗体活性的试剂盒和方法 |
KR102264116B1 (ko) * | 2019-06-19 | 2021-06-14 | 한국과학기술연구원 | 세포 소포체 내 g-단백질 연결 수용체(gpcr)의 실시간 활성 상태 분석 방법 및 컴퓨터 프로그램 |
CA3170531A1 (en) * | 2020-02-11 | 2021-08-19 | Absci Corporation | Proximity assay |
US20230265509A1 (en) * | 2022-02-18 | 2023-08-24 | David R. Kaplan | Novel targets for the treatment and diagnosis of patients with atherosclerosis and enhanced risk of end organ damage |
Family Cites Families (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4469863A (en) | 1980-11-12 | 1984-09-04 | Ts O Paul O P | Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof |
US4568649A (en) | 1983-02-22 | 1986-02-04 | Immunex Corporation | Immediate ligand detection assay |
US5235033A (en) | 1985-03-15 | 1993-08-10 | Anti-Gene Development Group | Alpha-morpholino ribonucleoside derivatives and polymers thereof |
US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
ES2035317T5 (es) * | 1987-11-09 | 1998-03-16 | Becton Dickinson Co | Metodo para analizar celulas hematopoyeticas en una muestra. |
US5216141A (en) | 1988-06-06 | 1993-06-01 | Benner Steven A | Oligonucleotide analogs containing sulfur linkages |
US4979824A (en) * | 1989-05-26 | 1990-12-25 | Board Of Trustees Of The Leland Stanford Junior University | High sensitivity fluorescent single particle and single molecule detection apparatus and method |
US5216414A (en) | 1989-11-20 | 1993-06-01 | Sharp Kabushiki Kaisha | Color liquid crystal display device |
US5386023A (en) | 1990-07-27 | 1995-01-31 | Isis Pharmaceuticals | Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling |
US5602240A (en) | 1990-07-27 | 1997-02-11 | Ciba Geigy Ag. | Backbone modified oligonucleotide analogs |
US5199576A (en) * | 1991-04-05 | 1993-04-06 | University Of Rochester | System for flexibly sorting particles |
US5234816A (en) | 1991-07-12 | 1993-08-10 | Becton, Dickinson And Company | Method for the classification and monitoring of leukemias |
US5644048A (en) | 1992-01-10 | 1997-07-01 | Isis Pharmaceuticals, Inc. | Process for preparing phosphorothioate oligonucleotides |
CA2117913C (en) * | 1992-04-10 | 2006-05-09 | Richard J. Epstein | Activation-state-specific phosphoprotein immunodetection |
US5637684A (en) | 1994-02-23 | 1997-06-10 | Isis Pharmaceuticals, Inc. | Phosphoramidate and phosphorothioamidate oligomeric compounds |
US5968738A (en) | 1995-12-06 | 1999-10-19 | The Board Of Trustees Of The Leland Stanford Junior University | Two-reporter FACS analysis of mammalian cells using green fluorescent proteins |
US5912137A (en) | 1996-07-16 | 1999-06-15 | The Regents Of The University Of California | Assays for protein kinases using fluorescent |
US6280967B1 (en) * | 1996-08-02 | 2001-08-28 | Axiom Biotechnologies, Inc. | Cell flow apparatus and method for real-time of cellular responses |
US6558916B2 (en) * | 1996-08-02 | 2003-05-06 | Axiom Biotechnologies, Inc. | Cell flow apparatus and method for real-time measurements of patient cellular responses |
US5804436A (en) * | 1996-08-02 | 1998-09-08 | Axiom Biotechnologies, Inc. | Apparatus and method for real-time measurement of cellular response |
EP1057036A1 (de) * | 1998-02-25 | 2000-12-06 | New York Medical College | Durchflusscytometrischer nachweis von konformationen von prb in einzelzellen |
US6821740B2 (en) * | 1998-02-25 | 2004-11-23 | Becton, Dickinson And Company | Flow cytometric methods for the concurrent detection of discrete functional conformations of PRB in single cells |
US7236888B2 (en) * | 1998-03-06 | 2007-06-26 | The Regents Of The University Of California | Method to measure the activation state of signaling pathways in cells |
CN100334227C (zh) | 1998-04-17 | 2007-08-29 | 里格尔制药公司 | 检测细胞参数变化和筛选小分子文库所用的多参数facs分析 |
WO1999058955A1 (en) | 1998-05-14 | 1999-11-18 | Luminex Corporation | Multi-analyte diagnostic system and computer implemented process for same |
FR2782730B1 (fr) | 1998-08-25 | 2002-05-17 | Biocom Sa | Procede de separation cellulaire pour l'isolation de cellules pathogeniques, notamment cancereuses rares, equipement et reactif pour la mise en oeuvre du procede et application du procede |
US7300753B2 (en) | 1998-09-04 | 2007-11-27 | John Rush | Immunoaffinity isolation of modified peptides from complex mixtures |
US6495333B1 (en) * | 1998-09-22 | 2002-12-17 | Becton Dickinson And Company | Flow cytometric, whole blood dendritic cell immune function assay |
US7351546B2 (en) * | 1998-09-22 | 2008-04-01 | Becton, Dickinson And Company | Flow cytometric, whole blood dendritic cell immune function assay |
AU762754B2 (en) | 1999-02-18 | 2003-07-03 | Regents Of The University Of California, The | Salicylamide-lanthanide complexes for use as luminescent markers |
US6972198B2 (en) * | 1999-02-26 | 2005-12-06 | Cyclacel, Ltd. | Methods and compositions using protein binding partners |
US7001725B2 (en) * | 1999-04-30 | 2006-02-21 | Aclara Biosciences, Inc. | Kits employing generalized target-binding e-tag probes |
ATE429259T1 (de) * | 1999-04-30 | 2009-05-15 | Childrens Hosp Medical Center | Hämofiltrationssystem |
US6673554B1 (en) | 1999-06-14 | 2004-01-06 | Trellie Bioinformatics, Inc. | Protein localization assays for toxicity and antidotes thereto |
US6406869B1 (en) | 1999-10-22 | 2002-06-18 | Pharmacopeia, Inc. | Fluorescent capture assay for kinase activity employing anti-phosphotyrosine antibodies as capture and detection agents |
JP2004509835A (ja) | 2000-03-06 | 2004-04-02 | ユニヴァーシティ オブ ケンタッキー リサーチ ファンデーション | 血液癌前駆細胞を障害する方法およびその関連化合物 |
US6763307B2 (en) * | 2000-03-06 | 2004-07-13 | Bioseek, Inc. | Patient classification |
CA2400989C (en) * | 2000-03-06 | 2014-09-30 | Bioseek, Inc. | Function homology screening |
WO2001077684A2 (en) * | 2000-04-10 | 2001-10-18 | The Scripps Research Institute | Proteomic analysis using activity-based probe libraries |
US7045286B2 (en) | 2000-07-25 | 2006-05-16 | The Trustees Of The University Of Pennsylvania | Methods of detecting molecules expressing selected epitopes via fluorescent dyes |
CA2423039A1 (en) * | 2000-09-20 | 2002-03-28 | Kinetek Pharmaceuticals, Inc. | Cancer associated protein kinases and their uses |
CA2438978A1 (en) * | 2001-02-28 | 2002-11-14 | Merck & Co., Inc. | Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof |
US7392199B2 (en) | 2001-05-01 | 2008-06-24 | Quest Diagnostics Investments Incorporated | Diagnosing inapparent diseases from common clinical tests using Bayesian analysis |
US20020197658A1 (en) * | 2001-05-10 | 2002-12-26 | Allen Delaney | Cancer associated protein kinase and its use |
US7393656B2 (en) | 2001-07-10 | 2008-07-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for risk stratification |
US7695926B2 (en) | 2001-07-10 | 2010-04-13 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for detecting receptor-ligand interactions in single cells |
ATE441857T1 (de) * | 2001-07-10 | 2009-09-15 | Univ Leland Stanford Junior | Verfahren und zusammensetzungen zum nachweis des aktivierungszustands multipler proteine in einzelzellen |
US7381535B2 (en) * | 2002-07-10 | 2008-06-03 | The Board Of Trustees Of The Leland Stanford Junior | Methods and compositions for detecting receptor-ligand interactions in single cells |
EP2277991A1 (de) * | 2001-08-21 | 2011-01-26 | Ventana Medical Systems, Inc. | Verfahren und Quantifizierungstest zur Bestimmung des c-Kit-/SCF-/pAkt-Status |
US20030148321A1 (en) | 2001-08-24 | 2003-08-07 | Iris Pecker | Methods and kits for diagnosing and monitoring hematopoietic cancers |
AU2002336504A1 (en) * | 2001-09-12 | 2003-03-24 | The State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of Oregon S | Method and system for classifying a scenario |
US7894992B2 (en) | 2001-11-07 | 2011-02-22 | Board Of Trustees Of The University Of Arkansas | Diagnosis and classification of multiple myeloma |
JP2005523688A (ja) * | 2002-01-18 | 2005-08-11 | ブリストル−マイヤーズ スクイブ カンパニー | タンパク質チロシンキナーゼおよび/またはタンパク質チロシンキナーゼ経路と相互作用する化合物の活性を予測するためのポリヌクレオチドおよびポリペプチドの同定 |
US7183385B2 (en) * | 2002-02-20 | 2007-02-27 | Cell Signaling Technology, Inc. | Phospho-specific antibodies to Flt3 and uses thereof |
US20050281743A1 (en) * | 2002-03-28 | 2005-12-22 | Delaney Allen D | Cancer associated protein phosphatases and their uses |
WO2003083096A2 (en) | 2002-03-28 | 2003-10-09 | Qlt Inc. | Cancer associated protein kinases and their uses |
US20030190688A1 (en) * | 2002-04-05 | 2003-10-09 | Cell Signaling Technology, Inc. | Methods for detecting BCR-ABL signaling activity in tissues using phospho-specific antibodies |
US20040248151A1 (en) * | 2002-04-05 | 2004-12-09 | Ventana Medical Systems, Inc. | Method for predicting the response to HER2-directed therapy |
US20030190689A1 (en) * | 2002-04-05 | 2003-10-09 | Cell Signaling Technology,Inc. | Molecular profiling of disease and therapeutic response using phospho-specific antibodies |
US7329502B2 (en) | 2002-04-25 | 2008-02-12 | The United States Of America As Represented By The Department Of Health And Human Services | ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) |
WO2004042347A2 (en) | 2002-05-03 | 2004-05-21 | Molecular Probes, Inc. | Compositions and methods for detection and isolation of phosphorylated molecules |
US7460960B2 (en) * | 2002-05-10 | 2008-12-02 | Epitome Biosystems, Inc. | Proteome epitope tags and methods of use thereof in protein modification analysis |
AU2003256453A1 (en) * | 2002-07-03 | 2004-01-23 | The Trustees Of Columbia University In The City Of New York | Methods for identifying modulators of mda-7 mediated apoptosis |
AU2003249284A1 (en) * | 2002-07-12 | 2004-02-02 | Rigel Pharmaceuticals, Inc. | Modulators of cellular proliferation |
US7537891B2 (en) * | 2002-08-27 | 2009-05-26 | Bristol-Myers Squibb Company | Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells |
US20040137539A1 (en) * | 2003-01-10 | 2004-07-15 | Bradford Sherry A. | Cancer comprehensive method for identifying cancer protein patterns and determination of cancer treatment strategies |
US20040229284A1 (en) * | 2003-02-19 | 2004-11-18 | The Regents Of The University Of California | Multiplex analysis of proteins |
US7507548B2 (en) * | 2003-03-04 | 2009-03-24 | University Of Salamanca | Multidimensional detection of aberrant phenotypes in neoplastic cells to be used to monitor minimal disease levels using flow cytometry measurements |
US20050009112A1 (en) * | 2003-03-07 | 2005-01-13 | Fred Hutchinson Cancer Research Center, Office Of Technology Transfer | Methods for identifying Rheb effectors as lead compounds for drug development for diabetes and diseases associated with abnormal cell growth |
JP2006522340A (ja) | 2003-04-02 | 2006-09-28 | メルク エンド カムパニー インコーポレーテッド | 質量分析データの分析法 |
WO2005001115A2 (en) * | 2003-05-30 | 2005-01-06 | Odyssey Thera, Inc. | Monitoring gene silencing and annotating gene function in living cells |
US7402399B2 (en) * | 2003-10-14 | 2008-07-22 | Monogram Biosciences, Inc. | Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy |
US7326577B2 (en) * | 2003-10-20 | 2008-02-05 | Esoterix, Inc. | Cell fixation and use in phospho-proteome screening |
US20060035211A1 (en) * | 2004-08-12 | 2006-02-16 | Douglas Levinson | Methods for identifying conditions affecting a cell state |
US20060040338A1 (en) * | 2004-08-18 | 2006-02-23 | Odyssey Thera, Inc. | Pharmacological profiling of drugs with cell-based assays |
US7803523B2 (en) | 2004-08-27 | 2010-09-28 | University Health Network | Whole blood preparation for cytometric analysis of cell signaling pathways |
ATE534909T1 (de) | 2004-12-22 | 2011-12-15 | California Inst Of Techn | Verfahren zur proteomischen profilierung mithilfe nichtnatürlicher aminosäuren |
CA2593355A1 (en) | 2005-01-24 | 2006-07-27 | The Board Of Trustees Of The Leland Stanford Junior University | Method for modeling cell signaling systems by means of bayesian networks |
WO2006096704A2 (en) | 2005-03-07 | 2006-09-14 | Invitrogen Corporation | Isotopically-labeled proteome standards |
JP5421590B2 (ja) | 2005-05-18 | 2014-02-19 | ノバルティス アーゲー | 自己免疫および/または炎症性成分を有する疾患の診断および治療のための方法 |
JP2007046697A (ja) | 2005-08-10 | 2007-02-22 | Fujikin Inc | 継手付き流体制御器 |
US9168286B2 (en) | 2005-10-13 | 2015-10-27 | Human Genome Sciences, Inc. | Methods and compositions for use in treatment of patients with autoantibody positive disease |
US20070105165A1 (en) | 2005-11-04 | 2007-05-10 | Charles Goolsby | Composite profiles of cell antigens and target signal transduction proteins for analysis and clinical management of hematologic cancers |
WO2007117423A2 (en) | 2006-03-31 | 2007-10-18 | Cira Discovery Sciences, Inc. | Method and apparatus for representing multidimensional data |
EP2860247A1 (de) | 2007-08-21 | 2015-04-15 | Nodality, Inc. | Diagnose-, Prognose- und Behandlungsverfahren |
US7892770B2 (en) | 2007-08-24 | 2011-02-22 | Van Andel Research Institute | Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods |
GB2474146B (en) | 2008-04-29 | 2013-04-10 | Nodality Inc | Methods of determining the health status of an individual |
US20090269800A1 (en) | 2008-04-29 | 2009-10-29 | Todd Covey | Device and method for processing cell samples |
US20090291458A1 (en) | 2008-05-22 | 2009-11-26 | Nodality, Inc. | Method for Determining the Status of an Individual |
US8227202B2 (en) | 2008-07-10 | 2012-07-24 | Nodality, Inc. | Methods for diagnosis, prognosis and methods of treatment |
US20100030719A1 (en) | 2008-07-10 | 2010-02-04 | Covey Todd M | Methods and apparatus related to bioinformatics data analysis |
US8399206B2 (en) | 2008-07-10 | 2013-03-19 | Nodality, Inc. | Methods for diagnosis, prognosis and methods of treatment |
WO2010006303A2 (en) | 2008-07-10 | 2010-01-14 | Nodality, Inc. | Methods and apparatus related to management of experiments |
US20100014741A1 (en) | 2008-07-10 | 2010-01-21 | Banville Steven C | Methods and apparatus related to gate boundaries within a data space |
CN102144161B (zh) | 2008-09-04 | 2016-02-17 | 贝克曼考尔特公司 | 泛激酶活化与信号通路的评估 |
WO2010045651A1 (en) | 2008-10-17 | 2010-04-22 | Nodality, Inc. | Methods for analyzing drug response |
US9034257B2 (en) | 2008-10-27 | 2015-05-19 | Nodality, Inc. | High throughput flow cytometry system and method |
US8309306B2 (en) | 2008-11-12 | 2012-11-13 | Nodality, Inc. | Detection composition |
US20100209929A1 (en) | 2009-01-14 | 2010-08-19 | Nodality, Inc., A Delaware Corporation | Multiple mechanisms for modulation of jak/stat activity |
US20100204973A1 (en) | 2009-01-15 | 2010-08-12 | Nodality, Inc., A Delaware Corporation | Methods For Diagnosis, Prognosis And Treatment |
US20100233733A1 (en) | 2009-02-10 | 2010-09-16 | Nodality, Inc., A Delaware Corporation | Multiple mechanisms for modulation of the pi3 kinase pathway |
US20100215644A1 (en) | 2009-02-25 | 2010-08-26 | Nodality, Inc. A Delaware Corporation | Analysis of nodes in cellular pathways |
US8242248B2 (en) | 2009-03-23 | 2012-08-14 | Nodality, Inc. | Kits for multiparametric phospho analysis |
US8187885B2 (en) | 2009-05-07 | 2012-05-29 | Nodality, Inc. | Microbead kit and method for quantitative calibration and performance monitoring of a fluorescence instrument |
WO2010135608A1 (en) | 2009-05-20 | 2010-11-25 | Nodality, Inc. | Methods for diagnosis, prognosis and methods of treatment |
US20110059861A1 (en) | 2009-09-08 | 2011-03-10 | Nodality, Inc. | Analysis of cell networks |
US20130071860A1 (en) | 2010-02-24 | 2013-03-21 | Matthew B. Hale | Methods for autoimmune disease diagnosis, prognosis, and treatment` |
US20110262468A1 (en) | 2010-04-23 | 2011-10-27 | Nodality, Inc. | Method for Monitoring Vaccine Response Using Single Cell Network Profiling |
WO2011156654A2 (en) | 2010-06-09 | 2011-12-15 | Nodality, Inc. | Pathways characterization of cells |
-
2002
- 2002-07-10 AT AT02805693T patent/ATE441857T1/de not_active IP Right Cessation
- 2002-07-10 US US10/193,462 patent/US7563584B2/en not_active Expired - Fee Related
- 2002-07-10 AU AU2002365421A patent/AU2002365421A1/en not_active Abandoned
- 2002-07-10 EP EP02805693A patent/EP1415156B1/de not_active Expired - Lifetime
- 2002-07-10 WO PCT/US2002/022328 patent/WO2003067210A2/en active Application Filing
- 2002-07-10 DE DE60233574T patent/DE60233574D1/de not_active Expired - Lifetime
- 2002-07-10 JP JP2003566512A patent/JP4401172B2/ja not_active Expired - Fee Related
-
2009
- 2009-02-17 US US12/372,670 patent/US8148094B2/en not_active Expired - Fee Related
-
2011
- 2011-04-26 US US13/094,737 patent/US8815527B2/en not_active Expired - Fee Related
- 2011-04-26 US US13/094,735 patent/US8962263B2/en not_active Expired - Fee Related
- 2011-05-02 US US13/098,923 patent/US20110250614A1/en not_active Abandoned
-
2015
- 2015-02-11 US US14/619,997 patent/US20150241442A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20110250614A1 (en) | 2011-10-13 |
WO2003067210A9 (en) | 2004-03-18 |
EP1415156A4 (de) | 2006-08-09 |
US20150241442A1 (en) | 2015-08-27 |
US20130177970A1 (en) | 2013-07-11 |
US8962263B2 (en) | 2015-02-24 |
EP1415156A2 (de) | 2004-05-06 |
US8815527B2 (en) | 2014-08-26 |
ATE441857T1 (de) | 2009-09-15 |
WO2003067210A2 (en) | 2003-08-14 |
WO2003067210A3 (en) | 2003-12-18 |
AU2002365421A8 (en) | 2003-09-02 |
AU2002365421A1 (en) | 2003-09-02 |
US20060073474A1 (en) | 2006-04-06 |
US20110020839A1 (en) | 2011-01-27 |
US8148094B2 (en) | 2012-04-03 |
JP2005517174A (ja) | 2005-06-09 |
EP1415156B1 (de) | 2009-09-02 |
JP4401172B2 (ja) | 2010-01-20 |
US7563584B2 (en) | 2009-07-21 |
US20120309026A1 (en) | 2012-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60233574D1 (de) | Verfahren und zusammensetzungen zum nachweis des aktivierungszustands multipler proteine in einzelzellen | |
ATE462016T1 (de) | System zum nachweis von tierprodukten | |
ATE264717T1 (de) | Mikrofluidisches system und verfahren zu dessen betrieb | |
DK1421215T3 (da) | Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA | |
WO2002003075A3 (en) | Methods for detecting activity of clotting factors | |
DE602004029107D1 (de) | System zum Sortieren und zur Reihenfolgeplanung von Postsendungen | |
AU4007401A (en) | Function homology screening | |
WO2004094671A3 (en) | Methods and products for identification and assessment of tlr ligands | |
ATE540319T1 (de) | Verfahren für die bestimmung von fk506 | |
ATE449869T1 (de) | Verfahren zur beurteilung der wirksamkeit von chemotherapeutika | |
EP2662453A3 (de) | Nachweis und Behandlung von Schizophrenie | |
NO20055025L (no) | Multiplex screening for lysosomale lagringsforstyrrelser (LSD) | |
AU2085502A (en) | Diagnosis and treatment of disease | |
ATE466080T1 (de) | Formulierungen und verfahren zum denaturieren von proteinen | |
DE602006013143D1 (de) | Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate | |
DE60318900D1 (de) | Nukleinsäuren, polypeptide und verfahren zur modulierung der apoptose | |
DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
DE60221550D1 (de) | Methode zur bestimmung der zellzyklusposition | |
DE60126991D1 (de) | Verfahren ZUR DIAGNOSE VON SCHIZOPHRENIE | |
DE68905918T2 (de) | Herbizides mittel, dessen verwendung und verfahren zur selektiven unkrautbekaempfung in getreide- und reiskulturen. | |
ATE384804T1 (de) | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG UND ZUR DETEKTION VON PROLIFERATIVEN STÖRUNGEN DIE MIT DER ÜBEREXPRESSION DES MENSCHLICHEN ßTRANSKETOLASE LIKE-1ß GENS IN ZUSAMMENHANG STEHEN | |
DE60321487D1 (de) | Verfahren zur identifizierung und quantifizierung von proteinen, isoformen des angiotensin i umsetzenden enzyms | |
WO2004108009A3 (en) | Method and kit for assessing risk for bovine respiratory disease | |
DE50211704D1 (de) | Verwendung eines markierten liganden mit spezifität für das humane cd4-molekül | |
Basu | Current Membership in Professional Organizations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |